Equities

Charmacy Pharmaceutical Co Ltd

Charmacy Pharmaceutical Co Ltd

Actions
  • Price (HKD)9.80
  • Today's Change0.50 / 5.38%
  • Shares traded7.00k
  • 1 Year change-24.62%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue4,4044,1753,794
OPERATING EXPENSES
Cost of revenue total4,1203,9143,565
Selling, general and admin. expenses, total142133118
Depreciation/amortization293333
Unusual expense(income)4.31(63)2.95
Other operating expenses, total5.495.544.18
Total operating expense4,3374,0543,761
Operating income6612232
Other, net1.220.530.59
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6712233
Provision for income taxes16329.83
Net income after taxes519023
Minority interest------
Net income before extra. Items519023
Total extraordinary items------
Net income519023
Inc.avail. to common excl. extra. Items519023
Inc.avail. to common incl. extra. Items519023
EPS RECONCILIATION
Basic/primary weighted average shares108108108
Basic/primary eps excl. extra items0.480.840.21
Basic/primary eps incl. extra items0.480.840.21
Dilution adjustment------
Diluted weighted average shares108108108
Diluted eps excl. extra items0.480.840.21
Diluted eps incl. extra items0.480.840.21
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.300.440
Gross dividend - common stock--490
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental413542
SUPPLEMENTAL INCOME
Depreciation, supplemental222526
Total special items4.31(63)2.95
NORMALISED INCOME
Normalized income before taxes725936
Effect of special items on income taxes1.03(16)0.88
Income tax excluding impact of special items171511
Normalized income after tax554425
Normalized income avail. to common554425
Basic normalized EPS0.510.410.23
Diluted normalized EPS0.510.410.23
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.